Hence, its reduced expression in tamoxifen-resistant tumor cells may contribute to apoptosis and cell survival, and translocation of NR4A1 to the cytoplasm from the nucleus by various agents, including cytosporone B and C-DIM [43,44] may serve as a unique therapeutic strategy. Here, NR4A1 is linked to neoplasm.